FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2610389611> ?p ?o ?g. }

• W2610389611 endingPage "3659" @default.
• W2610389611 startingPage "3651" @default.
• W2610389611 abstract "Docetaxel-based chemotherapy has been widely used as the first-line treatment for castration-resistant prostate cancer (CRPC) patients. However, the mechanisms of docetaxel-resistance remain unclear. In the present study with the establishment of 2 in vitro models of docetaxel-resistant CRPC cell sublines, we firstly reported that activation of calpain may play a promotional role in the resistance of docetaxel in prostate cancer, meanwhile using the calpain inhibitor combined with docetaxel improved the efficiency of docetaxel in docetaxel-resistant cell sublines. Moreover, we also found that the expression of androgen-independent constitutively and transcriptionally active androgen receptor splice variant-7 (AR-V7) remained high in the docetaxel-resistant CRPC cell subline Rv1-DR, and that it may be involved in acquired docetaxel-resistance of CRPC. However, a novel importin-β inhibitor (importazole) was only capable of slightly decreasing the transcriptional activity of the AR signaling pathway via blocking nuclear import of AR-FL and various non-specific AR-Vs, instead of AR-V7. These findings suggest that calpain and AR-V7 may serve as important biomarkers in the treatment of CRPC, and targeting calpain and AR-V7 may provide a new approach in overcoming docetaxel-resistance." @default.
• W2610389611 created "2017-05-12" @default.
• W2610389611 creator A5002239729 @default.
• W2610389611 creator A5012259172 @default.
• W2610389611 creator A5016729352 @default.
• W2610389611 creator A5028467654 @default.
• W2610389611 creator A5032085827 @default.
• W2610389611 creator A5046777605 @default.
• W2610389611 creator A5050504110 @default.
• W2610389611 creator A5054361001 @default.
• W2610389611 creator A5058214706 @default.
• W2610389611 creator A5059194803 @default.
• W2610389611 creator A5060493701 @default.
• W2610389611 creator A5062690647 @default.
• W2610389611 creator A5065703201 @default.
• W2610389611 creator A5089272863 @default.
• W2610389611 creator A5090872049 @default.
• W2610389611 date "2017-05-04" @default.
• W2610389611 modified "2023-10-16" @default.
• W2610389611 title "Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells" @default.
• W2610389611 cites W1594723233 @default.
• W2610389611 cites W1654777185 @default.
• W2610389611 cites W1907437151 @default.
• W2610389611 cites W1965053172 @default.
• W2610389611 cites W1969202480 @default.
• W2610389611 cites W1971579914 @default.
• W2610389611 cites W1978028702 @default.
• W2610389611 cites W2004952453 @default.
• W2610389611 cites W2005958584 @default.
• W2610389611 cites W2013933651 @default.
• W2610389611 cites W2020579083 @default.
• W2610389611 cites W2021754267 @default.
• W2610389611 cites W2024534768 @default.
• W2610389611 cites W2027596550 @default.
• W2610389611 cites W2049866636 @default.
• W2610389611 cites W2060184827 @default.
• W2610389611 cites W2060421144 @default.
• W2610389611 cites W2075004958 @default.
• W2610389611 cites W2077244514 @default.
• W2610389611 cites W2078145809 @default.
• W2610389611 cites W2085847636 @default.
• W2610389611 cites W2086594864 @default.
• W2610389611 cites W2088108760 @default.
• W2610389611 cites W2090137644 @default.
• W2610389611 cites W2106571316 @default.
• W2610389611 cites W2107013933 @default.
• W2610389611 cites W2109537367 @default.
• W2610389611 cites W2110841612 @default.
• W2610389611 cites W2114022883 @default.
• W2610389611 cites W2116607127 @default.
• W2610389611 cites W2120292596 @default.
• W2610389611 cites W2123629153 @default.
• W2610389611 cites W2125069527 @default.
• W2610389611 cites W2149131962 @default.
• W2610389611 cites W2152205343 @default.
• W2610389611 cites W2156923287 @default.
• W2610389611 cites W2157980218 @default.
• W2610389611 cites W2160999199 @default.
• W2610389611 cites W2162164344 @default.
• W2610389611 cites W2169436026 @default.
• W2610389611 cites W2169681364 @default.
• W2610389611 cites W2170668585 @default.
• W2610389611 cites W2171309933 @default.
• W2610389611 cites W2253090940 @default.
• W2610389611 cites W2345664901 @default.
• W2610389611 cites W2418869537 @default.
• W2610389611 cites W4205145397 @default.
• W2610389611 doi "https://doi.org/10.3892/or.2017.5623" @default.
• W2610389611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28498452" @default.
• W2610389611 hasPublicationYear "2017" @default.
• W2610389611 type Work @default.
• W2610389611 sameAs 2610389611 @default.
• W2610389611 citedByCount "4" @default.
• W2610389611 countsByYear W26103896112018 @default.
• W2610389611 countsByYear W26103896112020 @default.
• W2610389611 countsByYear W26103896112023 @default.
• W2610389611 crossrefType "journal-article" @default.
• W2610389611 hasAuthorship W2610389611A5002239729 @default.
• W2610389611 hasAuthorship W2610389611A5012259172 @default.
• W2610389611 hasAuthorship W2610389611A5016729352 @default.
• W2610389611 hasAuthorship W2610389611A5028467654 @default.
• W2610389611 hasAuthorship W2610389611A5032085827 @default.
• W2610389611 hasAuthorship W2610389611A5046777605 @default.
• W2610389611 hasAuthorship W2610389611A5050504110 @default.
• W2610389611 hasAuthorship W2610389611A5054361001 @default.
• W2610389611 hasAuthorship W2610389611A5058214706 @default.
• W2610389611 hasAuthorship W2610389611A5059194803 @default.
• W2610389611 hasAuthorship W2610389611A5060493701 @default.
• W2610389611 hasAuthorship W2610389611A5062690647 @default.
• W2610389611 hasAuthorship W2610389611A5065703201 @default.
• W2610389611 hasAuthorship W2610389611A5089272863 @default.
• W2610389611 hasAuthorship W2610389611A5090872049 @default.
• W2610389611 hasBestOaLocation W26103896111 @default.
• W2610389611 hasConcept C121608353 @default.
• W2610389611 hasConcept C126322002 @default.
• W2610389611 hasConcept C143998085 @default.
• W2610389611 hasConcept C181199279 @default.
• W2610389611 hasConcept C2780192828 @default.

• next